The Latest Cardiac and Vascular News
Non-invasive, AI-enabled product helps CT readers to accurately*, efficiently, and consistently identify narrowings in the coronary arteries, advancing the HeartFlow portfolio MOUNTAIN VIEW, Calif., April 17, 2023 (GLOBE NEWSWIRE) — HeartFlow, Inc. today announced the launch of the RoadMap analysis, a new AI-enabled product that assists CT readers to accurately*, […]
Financing will further drive commercial scale for HeartFlow’s AI-enabled portfolio of precision heart care products MOUNTAIN VIEW, Calif., April 06, 2023 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the close of a $215 million Series F funding round by its parent company HeartFlow […]
Late-breaking Data Demonstrate AHA/ACC Guideline-directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment MOUNTAIN VIEW, […]
HeartFlow is the first and only company to provide non-invasive anatomy, physiology, and plaque information based on coronary computed tomography angiography (CCTA) MOUNTAIN VIEW, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, has received U.S. Food and Drug Administration (FDA) 510(k) clearance on […]
MOUNTAIN VIEW, Calif., April 04, 2022 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced that Monica Tellado has been appointed Chief Financial Officer (CFO), effective April 4, 2022. “Monica is a high-impact leader with an outstanding track record of delivering results and creating value,” said […]
John Farquhar Appointed CEO, John Stevens to Become Vice Chair, Board of Directors MOUNTAIN VIEW, Calif., March 01, 2022 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced that John Farquhar has been appointed President and Chief Executive Officer, effective March 1, 2022. Mr. Farquhar has […]
REDWOOD CITY, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) — HeartFlow Holding, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Timothy Barabe to its Board of Directors. “We are honored to have an accomplished leader like Tim join the HeartFlow Board,” said William C. Weldon, Chairman of […]
Advanced innovations leverage HeartFlow’s core AI technology and are critical additions to HeartFlow’s product portfolio for delivering complete cardiac care REDWOOD CITY, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced it has submitted a 510k premarket application to the U.S. Food […]
REDWOOD CITY, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Wayne J. Riley, MD, to its Board of Directors. “We are very honored to have Dr. Riley join HeartFlow’s Board of Directors,” said William C. Weldon, Chairman of […]
REDWOOD CITY, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the Centers for Medicare & Medicaid Services (CMS) have established a national payment rate of $930.34 for the HeartFlow FFRct Analysis in office-based settings, such as doctors’ offices and imaging centers, […]
